NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs) in Nigeria
HIV Self-Testing and Long-Acting Injectables for HIV Treatment and Prevention Among Commercial Minibus Drivers (I-TEST LAIs) in Nigeria

NCT07000513

Not Yet RecruitingPhase 4

Sponsor: George Washington University

Conditions: HIV

Interventions: ITEST-LAI

Countries: Nigeria

Long-acting injectable antiretroviral therapy (LAI ART) and Pre-Exposure Prophylaxis (LAI PrEP) have the potential to transform HIV treatment and prevention, especially in reaching individuals such as commercial minibus drivers who have minimal or no contact with traditional health facilities. The project proposes to use a culturally appropriate and community-engaged approach to promote the uptake of HIV self-testing, LAI-ART, and LAI-PrEP among commercial minibus drivers in Nigeria by engaging commercial minibus drivers as peer educators/research facilitators.

Eligibility overview

Sex: MALE

Age: 18 Years to

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

1. Male commercial minibus drivers who have worked as a driver for at least 6 months
2. 18 years old or older
3. Currently and planning on residing in one of the LGAs during the next 12 months
4. Owning a mobile phone

Exclusion Criteria:

1. Known HIV positivity
2. Not ability to provide informed consent3
3. No access to a cell phone
Locations (1)
  • Lagos, Lagos, Nigeria